Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:27 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 13,908 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Type 1 Diabetes Mellitus
Interventions: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®, Colecalciferol 2000 IU, Placebo; Biological · Dietary Supplement
Lead sponsor: Diamyd Medical AB; Industry
Eligibility: 12 Years to 28 Years
Enrollment: 321 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 13
States / cities: Newport Beach, California • Palo Alto, California • San Diego, California + 10 more

Conditions: Dental Caries
Interventions: ZR Crown, Stainless Steel Crown; Device
Lead sponsor: NuSmile, Ltd.; Industry
Eligibility: 3 Years to 7 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 2
States / cities: San Antonio, Texas

Conditions: Alcohol Use Disorder
Interventions: Ibudilast, Placebo oral capsule; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Postoperative Respiratory Complications
Interventions: Lung protective strategy ventilation; Procedure
Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Other
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Boston, Massachusetts • Rochester, New York

Conditions: COVID-19
Interventions: Exercise Prescription; Other
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Frisco, Texas

Conditions: Head and Neck Cancer
Interventions: Guided Imagery, Treatment as Usual; Behavioral · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 100 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Dizziness, Vertigo
Interventions: Pentoxifylline, Placebo; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 40 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Congenital Heart Disease, Neurodevelopment, Executive Function, Working Memory Training, Infant Open-heart Surgery
Interventions: Cogmed Working Memory Training; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 13 Years to 16 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV Infections, Hepatitis C
Interventions: Ribavirin, Interferon alfa-2a, Peginterferon alfa-2a; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2006
U.S. locations: 24
States / cities: San Diego, California • San Francisco, California • Aurora, Colorado + 12 more

Conditions: Spinal Cord Injury
Interventions: Scheduled Telephone Intervention; Behavioral
Lead sponsor: Jeanne Hoffman; Other
Eligibility: 16 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Seattle, Washington

Conditions: Cerebrovascular Accident
Interventions: Magnesium Sulfate, Normal Saline; Drug
Lead sponsor: Jeffrey L. Saver; Other
Eligibility: 40 Years to 95 Years
Enrollment: 1,700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Proactive Outreach, No Proactive Outreach; Other
Lead sponsor: Harvard Medical School (HMS and HSDM); Other
Eligibility: Not listed
Enrollment: 19,113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Chicago, Illinois • Louisville, Kentucky • Boston, Massachusetts

Conditions: Obesity, Overweight, Weight Loss, Weight Maintenance
Interventions: Fit4Life; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 7 Years to 18 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Healthy
Interventions: IW-1701, Placebo; Drug
Lead sponsor: Cyclerion Therapeutics; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: COVID-19
Interventions: vitamin D, Placebo; Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 2,024 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases, Cardiovascular Diseases, Heart Valve Diseases
Interventions: Carillon Mitral Contour System, Guideline Directed Heart Failure Medication; Device · Other
Lead sponsor: Cardiac Dimensions, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2030
U.S. locations: 75
States / cities: Gilbert, Arizona • Phoenix, Arizona • Tucson, Arizona + 61 more

Conditions: Injuries
Interventions: A pre-dive checklist; Other
Lead sponsor: Divers Alert Network; Network
Eligibility: 18 Years and older
Enrollment: 1,116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Lateral Ankle Instability
Interventions: MBP plus arthroscopy (Group A), MBP alone (Group B); Procedure
Lead sponsor: Edna Rath; Federal
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Pain, Postoperative, Hip Arthroplasty
Interventions: CMP, Fascia Illica; Drug
Lead sponsor: Loyola University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Olanzapine; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 33
States / cities: Anaheim, California • National City, California • Orange, California + 30 more

Conditions: Dietary Habits, Health Behavior, Eating Behavior
Interventions: Behavioral Gardening Exposure, Healthy Eating and Gardening Curriculum; Behavioral
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 8 Years to 12 Years
Enrollment: 294 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Farmington, New Mexico • Seattle, Washington

Conditions: Retinitis Pigmentosa
Interventions: Vitamin A, Docosahexaenoic acid, Control fatty acid; Dietary Supplement
Lead sponsor: Carol Weigel DiFranco; NIH
Eligibility: 18 Years to 55 Years
Enrollment: 221 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1996 – 2002
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anxiety Disorders, Mental Health
Interventions: Hypericum perforatum (St. John's wort); Drug
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chronic Diabetic Foot Ulcers
Interventions: Dual Layer Amniotic Membrane (DLAM). Artacent®; Biological
Lead sponsor: SerenaGroup, Inc.; Network
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 15
States / cities: Phoenix, Arizona • Los Angeles, California • Pembroke Pines, Florida + 12 more

Search by objective public record fields.

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

Trial of a New NuSmile ZR Esthetic Primary Molar Crown

Ibudilast for the Treatment of Alcohol Use Disorder

PROVHILO:Protective Ventilation During General Anesthesia for Open Abdominal Surgery

Exercise in Adults with Post-Acute Sequelae of SARS-CoV-2 (COVID-19) Infection Study

Effect of Guided Imagery for Radiotherapy-Related Distress in Patients With Head and Neck Cancer

Trental for the Treatment of Vertigo/Dizziness/Imbalance

Improving Neurodevelopment in Adolescents With Congenital Heart Disease

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Scheduled Telephone Intervention for Individuals With Spinal Cord Injury and Their Families

Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial

Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing

PACE-CALL: A Weight Control Intervention for Survivors of Childhood Leukemia

A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects

Vitamin D for COVID-19 Trial

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Common Recreational Diving Practices: A Randomized Control Trial Using Pre-Dive Checklist

Modified Brostrӧm Procedure With and Without Possible Arthroscopy for Lateral Ankle Instability

CMP vs Fascia Iliaca Block

Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder

Yeego! Healthy Eating & Gardening School-Based Randomized Controlled Trial

Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A

St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)

Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)